AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Crassula Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR

Triveo-DM 2mg/500mg/0.2mg extended-release tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer Triveo-DM with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can elevate blood sugar, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Pregnant or lactating individuals should consult their physician. Regular blood glucose monitoring is essential, along with potential blood tests to monitor blood cell counts and liver function.

Uses of Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this extended-release tablet on an empty stomach.

Common Side effects of Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Take it on an empty stomach.

How Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR works:

Gemprime Trio LV extended-release tablets (2mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gemprime Trio LV 2mg/500mg/0.2mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gemprime Trio LV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Gemprime Trio LV 2mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Gemprime Trio LV 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Gemprime Trio LV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. In individuals with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR :

Should you forget a Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR

Gemprime Trio LV (Glimepiride 2mg/Metformin 500mg/Voglibose 0.2mg) extended-release tablets treat type 2 diabetes mellitus in adults. This triple-combination medication improves blood glucose control when used with diet and exercise. Glimepiride boosts insulin release, Metformin reduces liver glucose production and enhances insulin sensitivity, while Voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Gemprime Trio LV 2mg/500mg/0.2mg SR tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Gemprime Trio LV 2mg/500mg/0.2mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Gemprime Trio LV 2mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gemprime Trio LV 2mg/500mg/0.2mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Gemprime Trio LV 2mg/500m...
90
MRP 110
18% off